Enhancing the efficacy of viral vector blood-stage malaria vaccines
<p>Replication-deficient adenovirus (Ad) and modified vaccinia virus Ankara (MVA) vectors expressing single Plasmodium falciparum antigens can induce potent T cell and antibody responses and have entered clinical testing using a heterologous prime-boost immunisation approach (Ad_MVA). This the...
第一著者: | Forbes, E |
---|---|
その他の著者: | Hill, A |
フォーマット: | 学位論文 |
言語: | English |
出版事項: |
2011
|
主題: |
類似資料
-
Pre-clinical development of viral vectored transmission-blocking malaria vaccines
著者:: Kapulu, MC
出版事項: (2014) -
Developing novel blood-stage malaria vaccines
著者:: Douglas, AD
出版事項: (2015) -
Malaria pre-erythrocytic stage vaccines: targeting antigen combinations
著者:: Bauza, K
出版事項: (2012) -
Towards improved blood-stage malaria vaccines: characterising the underlying immunogenicity of vaccine adjuvants and vectors
著者:: de Cassan, S
出版事項: (2011) -
Analysis of b cell responses to blood-stage malaria antigens in humans following immunization with candidate vaccines and controlled human malaria infection
著者:: Elias, SC
出版事項: (2014)